A Study to Evaluate the Effect of Umeclidinium (UMEC) as Combination Therapy in Subjects With Chronic Obstructive Pulmonary Disease (COPD)

Condition: Pulmonary Disease, Chronic ObstructiveInterventions: Drug: UMEC DPI; Drug: Placebo DPI; Drug: ICS/LABA medication; Drug: Albuterol/salbutamol Metered Dose Inhaler (MDI)Sponsor: GlaxoSmithKlineCompleted - verified April 2015

http://clinicaltrials.gov/ct2/show/NCT02257372?lup_s=04%2F04%2F2015&lup_d=30

Source: ClinicalTrials.gov - October 2, 2014 Category: Research Source Type: clinical trials